PL3092243T3 - Odczynniki cynoorganiczne na nośniku cieczy jonowej do wytwarzania związków radiofarmaceutycznych - Google Patents

Odczynniki cynoorganiczne na nośniku cieczy jonowej do wytwarzania związków radiofarmaceutycznych

Info

Publication number
PL3092243T3
PL3092243T3 PL15700962T PL15700962T PL3092243T3 PL 3092243 T3 PL3092243 T3 PL 3092243T3 PL 15700962 T PL15700962 T PL 15700962T PL 15700962 T PL15700962 T PL 15700962T PL 3092243 T3 PL3092243 T3 PL 3092243T3
Authority
PL
Poland
Prior art keywords
radiopharmaceuticals
compounds
manufacturing
ionic liquid
liquid supported
Prior art date
Application number
PL15700962T
Other languages
English (en)
Polish (pl)
Inventor
Stéphanie Legoupy
Djibril Faye
Jean-François GESTIN
Holisoa RAJERISON
Alain Faivre-Chauvet
Fabien Boeda
Original Assignee
Centre National De La Recherche Scientifique (Cnrs)
Université de Nantes
Université d'Angers
Université Du Maine
INSERM (Institut National de la Santé et de la Recherche Médicale)
Centre Hospitalier Universitaire De Nantes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National De La Recherche Scientifique (Cnrs), Université de Nantes, Université d'Angers, Université Du Maine, INSERM (Institut National de la Santé et de la Recherche Médicale), Centre Hospitalier Universitaire De Nantes filed Critical Centre National De La Recherche Scientifique (Cnrs)
Publication of PL3092243T3 publication Critical patent/PL3092243T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22—Tin compounds
    • C07F7/2208—Compounds having tin linked only to carbon, hydrogen and/or halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0006—Controlling or regulating processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/24—Stationary reactors without moving elements inside
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/008—Peptides; Proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/307—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/78—Benzoic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/24—Stationary reactors without moving elements inside
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL15700962T 2014-01-07 2015-01-07 Odczynniki cynoorganiczne na nośniku cieczy jonowej do wytwarzania związków radiofarmaceutycznych PL3092243T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14150296.3A EP2891657A1 (en) 2014-01-07 2014-01-07 Ionic liquid supported organotin reagents for the manufacturing of radiopharmaceuticals compounds
EP15700962.2A EP3092243B1 (en) 2014-01-07 2015-01-07 Ionic liquid supported organotin reagents for the manufacturing of radiopharmaceuticals compounds
PCT/EP2015/050180 WO2015104300A1 (en) 2014-01-07 2015-01-07 Ionic liquid supported organotin reagents for the manufacturing of radiopharmaceuticals compounds

Publications (1)

Publication Number Publication Date
PL3092243T3 true PL3092243T3 (pl) 2020-02-28

Family

ID=49883036

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15700962T PL3092243T3 (pl) 2014-01-07 2015-01-07 Odczynniki cynoorganiczne na nośniku cieczy jonowej do wytwarzania związków radiofarmaceutycznych

Country Status (8)

Country Link
US (1) US9714261B2 (enExample)
EP (2) EP2891657A1 (enExample)
JP (1) JP6639411B2 (enExample)
CA (1) CA2936034A1 (enExample)
DK (1) DK3092243T3 (enExample)
ES (1) ES2746255T3 (enExample)
PL (1) PL3092243T3 (enExample)
WO (1) WO2015104300A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112430243B (zh) * 2019-08-24 2023-03-21 江西师范大学 一种制备硫酯类化合物的方法
WO2021119198A1 (en) * 2019-12-09 2021-06-17 Cage Bio, Inc. Topical delivery of rna interference agents using ionic liquid
US20220356205A1 (en) * 2020-02-21 2022-11-10 National University Corporation Hokkaido University Method for producing aromatic astatine compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510522A (en) 1995-02-22 1996-04-23 Regents Of The University Of California Synthesis of N-formyl-3,4-di-t-butoxycarbonyloxy-6-(trimethylstannyl)-L-phenylalanine ethyl ester and its regioselective radiofluorodestannylation to 6- 18 F!fluoro-1-dopa
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
WO1999018053A1 (en) 1997-10-02 1999-04-15 The University Of Western Ontario Preparation of radiolabelled haloaromatics via polymer-bound intermediates
DE19928911B4 (de) 1999-06-24 2006-06-29 Forschungszentrum Rossendorf E.V. Verfahren zur Herstellung von 3-0-Methyl-6-[18F]Fluor-DOPA, (3-0-Methyl-6-[18F]Fluor-L-4-hydroxyphenylalanin, 3-(2-[18F]Fluor-4-hydroxy-5-methoxy-phenyl)-2-amino-propansäure)
DE19949237B4 (de) 1999-10-13 2004-07-29 Abx Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien Gmbh Vorstufenverbindung für Radiodiagnostika und Verfahren zu ihrer Herstellung
WO2010059943A2 (en) 2008-11-20 2010-05-27 President And Fellows Of Harvard College Fluorination of organic compounds

Also Published As

Publication number Publication date
WO2015104300A1 (en) 2015-07-16
JP2017504658A (ja) 2017-02-09
DK3092243T3 (da) 2019-09-30
EP2891657A1 (en) 2015-07-08
US20160326194A1 (en) 2016-11-10
CA2936034A1 (en) 2015-07-16
US9714261B2 (en) 2017-07-25
EP3092243A1 (en) 2016-11-16
ES2746255T3 (es) 2020-03-05
EP3092243B1 (en) 2019-06-19
JP6639411B2 (ja) 2020-02-05

Similar Documents

Publication Publication Date Title
ZA201800388B (en) Bicyclic¿fused heteroaryl or aryl compounds as irak4 modulators
GB201511435D0 (en) Liquid container
GB201504689D0 (en) Chemical compounds
GB201604680D0 (en) Chemical Compounds
IL252912B (en) Processes for preparing oxathiazine-like compounds
GB201609602D0 (en) Chemical compounds
GB201604681D0 (en) Chemical Compounds
PL3099664T3 (pl) Ciecze jonowe
SG11201700791YA (en) Process for the preparation of polyethercarbonate polyols
GB201614934D0 (en) Chemical compounds
GB201501025D0 (en) Chemical compounds
ZA201606598B (en) Novel fused imidazobenzothiazole compounds
PL3137056T3 (pl) Ciekłe zawiesiny farmaceutyczne zawierające bizmut
GB201602527D0 (en) Chemical compounds
GB201512286D0 (en) Chemical compounds
DK3092243T3 (da) Organotinreagenser båret af ionisk væske til fremstilling af radiofarmaceutiske forbindelser
IL258535B (en) Process for the preparation of organic halides
ZA201607136B (en) Chemical compounds
GB201614940D0 (en) Chemical compounds
PL3112162T3 (pl) Wkład z cieczą
GB2527766B (en) Contamination meter
GB201421153D0 (en) Reagent cartridge
PL3112164T3 (pl) Wkład z płynem
GB201420904D0 (en) Liquid filter - reservoir
GB201421211D0 (en) Chemical compounds